Oxford coronavirus vaccine first to enter final stages of testing
Oxford and AstraZeneca have the first coronavirus vaccine to enter the final stages of human testing.
News and updates on vaccine trials fighting COVID-19
Oxford and AstraZeneca have the first coronavirus vaccine to enter the final stages of human testing.
Inovio was granted $71 million from the Department of Defense for their vaccine development. The company is also developing needleless devices to inject it.
Chinese company Clover has begun Phase 1 trials for their coronavirus vaccine.
Moderna is on track to get their vaccine distributed in 2021. With government help, self-manufacturing, and experience, they’ve got a strong chance at it.